News
Novartis drops geographic atrophy gene therapy
Novartis has confirmed it will discontinue development of a gene …
19811 items found
Oncology
Cancer Moonshot: A story of hope for oncology in the US
The vision of ending cancer as we know it has long been a target for …
News
FDA clears new Pfizer, Moderna COVID jabs as cases tick up
The FDA has authorised updated versions of Pfizer/BioNTech and …
Digital
AI is enabling the rise of sophisticated digital therapeutics
Ben Hargreaves explores the capability of AI and machine learning to …
News
WCLC: Chemo adds efficacy and side effects to AZ's Tagrisso
Giving AstraZeneca's EGFR tyrosine kinase inhibitor (TKI) inhibitor …
News
First-in-class BMS drug raises lung fibrosis hopes
Bristol-Myers Squibb has proof-of-concept data for an experimental …
News
WCLC: Amgen eyes first-line use for KRAS drug Lumakras
Amgen is facing a slowdown in uptake of its first-to-market KRAS …
News
AZ's Alexion inks wide-ranging AI agreement with Verge
AstraZeneca has made a sizeable play in applying artificial …
News
WCLC: Data back first-line use of Gilead, AZ/Daiichi TROP2s
AstraZeneca/Daiichi Sankyo and Gilead Sciences have reported …
News
WCLC: Daiichi Sankyo HER3 ADC readout sets up filings
A mid-stage trial of Daiichi Sankyo's HER3-targeting antibody-drug …
Patients
Technology’s patient-centric vision will revolutionise the approach to patient safety
The future of patient-centricity in pharmacovigilance involves a …
News
Apollo, Nimbus lead bumper week for biotech financings
This week saw a series of big-ticket funding rounds for biotech …
News
Blueprint's mastocytosis drug Ayvakit cleared for NHS use
NICE has recommended broad use of Blueprint Medicines' recently-approved therapy for rare blood disorder advanced systemic mastocytosis (ASM) by the NHS in England and Wales, including firs
Digital
Sponsored
The AI effect in pharma commercial strategy: From data to re...
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
Patients
Deep Dive: Patients & Partnerships 2024
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
From neurosurgery to focused ultrasound: Not if, but when
Therapeutic or focused ultrasound began being applied to neurologic conditions less than a decade ago, but its potential in a wide spectrum of brain applications is high.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
Welcome to the Molecular Glue Drug Development Summit!
The Molecular Glue Drug Development Summit is back in January, 2025!
R&D
Partner Content
Welcome to the 6th RNAi-Based Therapeutics Summit!
RNAi-Based Therapeutics Returns!
